ShareValue scores for EPIT.TA: Valuation 45, Quality 52, Growth 45, Health 51.
EPIT.TATASE
Epitomee Medical Ltd
₪3.40
(-2.69%)
EPIT.TATASE
Epitomee Medical Ltd
₪3.40(-2.69%)
Loading chart...
Sentiment
Verdicts
Value:Fair Value
Quality:Moderate
Growth:Moderate
Health:Moderate
Verdicts
Fundamental Rating
Value Trap Risk
Expected Return
5% to 16%
Rating
Trap Risk
Return
5% to 16%
Valuation
45
Fair Value
Price vs Value
Quality
52
Moderate
Business Strength
Growth
45
Moderate
Revenue & Earnings
Health
51
Moderate
Financial Stability
Momentum
10
Bearish
Price Trend
Company Details
About
Epitomee Medical Ltd develops and commercializes ingestible therapeutic devices in Israel. The company offers capsules for the treatment of overweight and obesity. It also focuses on developing biologic drug delivery solutions. Epitomee Medical Ltd was incorporated in 2005 and is based in Caesarea, Israel.
Market Cap$102M
P/E RatioN/A
Dividend YieldNone
Sector Rank#1792
Score Analysis
AI Investment Thesis
Data as of:Aug 7, 2026
|Last calculated:Aug 7, 2026